Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark

被引:64
|
作者
Lyngse, Frederik Plesner [1 ,2 ,3 ,4 ]
Kirkeby, Carsten Thure
Denwood, Matthew
Christiansen, Lasse Engbo [6 ]
Molbak, Kare [4 ,5 ]
Moller, Camilla Holten [4 ]
Skov, Robert Leo [4 ]
Krause, Tyra Grove [4 ]
Rasmussen, Morten [4 ]
Sieber, Raphael Niklaus [4 ]
Johannesen, Thor Bech [4 ]
Lillebaek, Troels [4 ,7 ]
Fonager, Jannik [4 ]
Fomsgaard, Anders [4 ]
Moller, Frederik Trier [4 ]
Stegger, Marc [4 ]
Overvad, Maria [4 ]
Spiess, Katja [4 ]
Mortensen, Laust Hvas [8 ,9 ]
机构
[1] Univ Copenhagen, Dept Econ, Copenhagen, Denmark
[2] Univ Copenhagen, Ctr Econ Behav & Inequal, Copenhagen, Denmark
[3] Danish Minist Hlth, Copenhagen, Denmark
[4] Statens Serum Inst, Copenhagen, Denmark
[5] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark
[6] Tech Univ Denmark, Dept Appl Math & Comp Sci Dynam Syst, Lyngby, Denmark
[7] Univ Copenhagen, Global Hlth Sect, Copenhagen, Denmark
[8] Stat Denmark, Copenhagen, Denmark
[9] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark
基金
新加坡国家研究基金会;
关键词
D O I
10.1038/s41467-022-33498-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
SARS coronavirus 2 (SARS-CoV-2) continues to evolve and new variants emerge. Using nationwide Danish data, we estimate the transmission dynamics of SARS-CoV-2 Omicron subvariants BA.1 and BA.2 within households. Among 22,678 primary cases, we identified 17,319 secondary infections among 50,588 household contacts during a 1-7 day follow-up. The secondary attack rate (SAR) was 29% and 39% in households infected with Omicron BA.1 and BA.2, respectively. BA.2 was associated with increased susceptibility of infection for unvaccinated household contacts (Odds Ratio (OR) 1.99; 95%-CI 1.72-2.31), fully vaccinated contacts (OR 2.26; 95%-CI 1.95-2.62) and booster-vaccinated contacts (OR 2.65; 95%-CI 2.29-3.08), compared to BA.1. We also found increased infectiousness from unvaccinated primary cases infected with BA.2 compared to BA.1 (OR 2.47; 95%-CI 2.15-2.84), but not for fully vaccinated (OR 0.66; 95%-CI 0.57-0.78) or booster-vaccinated primary cases (OR 0.69; 95%-CI 0.59-0.82). Omicron BA.2 is inherently more transmissible than BA.1. Its immune-evasive properties also reduce the protective effect of vaccination against infection, but do not increase infectiousness of breakthrough infections from vaccinated individuals.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] A retrospective analysis of clinical features of patients hospitalized with SARS-CoV-2 Omicron variants BA.1 and BA.2
    Cristina Groza
    David Totschnig
    Christoph Wenisch
    Johanna Atamaniuk
    Alexander Zoufaly
    [J]. Scientific Reports, 13
  • [42] Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
    Bruel, Timothee
    Hadjadj, Jerome
    Maes, Piet
    Planas, Delphine
    Seve, Aymeric
    Staropoli, Isabelle
    Guivel-Benhassine, Florence
    Porrot, Francoise
    Bolland, William-Henry
    Nguyen, Yann
    Casadevall, Marion
    Charre, Caroline
    Pere, Helene
    Veyer, David
    Prot, Matthieu
    Baidaliuk, Artem
    Cuypers, Lize
    Planchais, Cyril
    Mouquet, Hugo
    Baele, Guy
    Mouthon, Luc
    Hocqueloux, Laurent
    Simon-Loriere, Etienne
    Andre, Emmanuel
    Terrier, Benjamin
    Prazuck, Thierry
    Schwartz, Olivier
    [J]. NATURE MEDICINE, 2022, 28 (06) : 1297 - +
  • [43] Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
    Timothée Bruel
    Jérôme Hadjadj
    Piet Maes
    Delphine Planas
    Aymeric Seve
    Isabelle Staropoli
    Florence Guivel-Benhassine
    Françoise Porrot
    William-Henry Bolland
    Yann Nguyen
    Marion Casadevall
    Caroline Charre
    Hélène Péré
    David Veyer
    Matthieu Prot
    Artem Baidaliuk
    Lize Cuypers
    Cyril Planchais
    Hugo Mouquet
    Guy Baele
    Luc Mouthon
    Laurent Hocqueloux
    Etienne Simon-Loriere
    Emmanuel André
    Benjamin Terrier
    Thierry Prazuck
    Olivier Schwartz
    [J]. Nature Medicine, 2022, 28 : 1297 - 1302
  • [44] Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections
    Qassim, Suelen H.
    Chemaitelly, Hiam
    Ayoub, Houssein H.
    AlMukdad, Sawsan
    Tang, Patrick
    Hasan, Mohammad R.
    Yassine, Hadi M.
    Al-Khatib, Hebah A.
    Smatti, Maria K.
    Abdul-Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al-Kuwari, Mohamed Ghaith
    Al-Khal, Abdullatif
    Coyle, Peter
    Kaleeckal, Anvar Hassan
    Shaik, Riyazuddin Mohammad
    Latif, Ali Nizar
    Al-Kuwari, Einas
    Jeremijenko, Andrew
    Butt, Adeel A.
    Bertollini, Roberto
    Al-Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Abu-Raddad, Laith J.
    [J]. JOURNAL OF TRAVEL MEDICINE, 2022, 29 (06)
  • [45] A retrospective analysis of clinical features of patients hospitalized with SARS-CoV-2 Omicron variants BA.1 and BA.2
    Groza, Cristina
    Totschnig, David
    Wenisch, Christoph
    Atamaniuk, Johanna
    Zoufaly, Alexander
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [46] Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection
    Zhang, Yidun
    Li, Jiaming
    Jiang, Lina
    Chen, Qi
    Fu, Yingying
    Jin, Yifei
    Chen, Zehui
    Tang, Fei
    Zeng, Xiaohong
    Wen, Huixin
    Lu, Bing
    Li, Li
    Zheng, Jing
    Wang, Zhongyi
    [J]. JOURNAL OF INFECTION, 2022, 85 (02) : E37 - E39
  • [47] The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5
    Shuai, Huiping
    Chan, Jasper Fuk-Woo
    Hu, Bingjie
    Chai, Yue
    Yoon, Chaemin
    Liu, Huan
    Liu, Yuanchen
    Shi, Jialu
    Zhu, Tianrenzheng
    Hu, Jing-Chu
    Hu, Ye-fan
    Hou, Yuxin
    Huang, Xiner
    Yuen, Terrence Tsz-Tai
    Wang, Yang
    Zhang, Jinjin
    Xia, Yao
    Chen, Lin-Lei
    Cai, Jian-Piao
    Zhang, Anna Jinxia
    Yuan, Shuofeng
    Zhou, Jie
    Zhang, Bao-Zhong
    Huang, Jian-Dong
    Yuen, Kwok-Yung
    To, Kelvin Kai-Wang
    Chu, Hin
    [J]. EBIOMEDICINE, 2023, 95
  • [48] Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants
    Zheng, Qianqian
    Duan, Liangwei
    Jiang, Zhihua
    Gu, Tingxuan
    Zhang, Bojie
    Li, Jiaoyang
    Zhang, Yang
    Zhang, Shiyu
    Liang, Yinming
    Wang, Hui
    [J]. GENES & DISEASES, 2023, 10 (03) : 664 - 667
  • [49] SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5
    Abbad, Anass
    Yellin, Temima
    Singh, Gagandeep
    Fried, Miriam
    Raskin, Ariel
    Tcheou, Johnstone
    Monahan, Brian
    Gleason, Charles
    Group, P. A. R. I. S. Study
    Simon, Viviana
    Carreno, Juan Manuel
    Krammer, Florian
    [J]. CELL REPORTS MEDICINE, 2024, 5 (03)
  • [50] Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages
    Ai, Jingwen
    Wang, Xun
    He, Xinyi
    Zhao, Xiaoyu
    Zhang, Yi
    Jiang, Yuchao
    Li, Minghui
    Cui, Yuchen
    Chen, Yanjia
    Qiao, Rui
    Li, Lin
    Yang, Lulu
    Li, Yi
    Hu, Zixin
    Zhang, Wenhong
    Wang, Pengfei
    [J]. CELL HOST & MICROBE, 2022, 30 (08) : 1077 - +